Search This Blog

Thursday, October 1, 2026

Sanofi, Regeneron expand immunology drug partnership with $1 b upfront, up to $7 b in milestones

 


  • Agreement covers development of four new antibody medicines in immunology
  • Deal includes settlement of a prior legal dispute between Sanofi and Regeneron
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)